JPRN-jRCT1080223252未知Unknown
Pharmacokinetic Clinical Reaserch of EVG/COBI/FTC/TAF FDC -Food effect on Pharmacokinetic Profiles in Japanese Healthy Adult Male Volunteers
试验速览
- 阶段
- Unknown
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 45age old（—）
- 性别
- Male
入选标准
- •(1) Healthy Japanese male aged between 20 and 45 years inclusive at obtaining informed consent
- •(2) Body mass index ([body weight (kg)] / [height (m)]2) of 18.5 to less than 25.0 at the screening tests
- •(3) Written informed consent for participation in the study
排除标准
- •(1) Subject with history of serious disorder affecting the brain, liver, kidneys, heart, lungs, gastrointestine, hematological system, endocrine system, psychiatrics, or others
- •(2) Deviation from the pre-defined reference values of blood pressure, pulse rate, or ECG
研究者
相似试验
已完成
1 期
VEG105424 : Study On Pazopanib When Given With FOLFOX6 (Fluorouracil, Oxaliplatin, Leucovorin) Or CapeOx (Capecitabine, Oxaliplatin)CTRI/2009/091/000516GlaxoSmithKline Pharmaceuticals Ltd.70
招募中
3 期
Various types of meropenem administration in patients with VAP snd ARCIRCT20130917014693N12Shahid Beheshti University of Medical Sciences60
已完成
1 期
The Pharmacokinetics/Pharmacodynamics and Safety/Tolerability of Evogliptin in Hemodialysis PatientsHemodialysis PatientsNCT04195919Dong-A ST Co., Ltd.17
进行中（未招募）
1 期
A Phase I study of BPX-501 T cells and AP1903 in children with recurrent hematological cancer after allogeneic transplant.recurrent or minimal residual disease (MRD) hematologic malignancies post-allogeneic transplantMedDRA version: 20.0Level: HLGTClassification code 10018849Term: Haematological disorders NECSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2015-005176-17-ITBellicum Pharmaceuticals, Inc.15
尚未招募
不适用
To evaluate the efficacy of lajjalu taila in uterine prolapseCTRI/2023/01/048677Shri BMK Ayurveda Mahavidyalaya